ENGLISH
ÑÇÖÞ±ØÓ®×ÊѶ
News
ÑÇÖÞ±ØÓ®Ò½Ò©¼ÓÈëÃÀ¹úÐÂÈñϸ°ûÖÎÁƹ«Ë¾BÂÖÈÚ×Ê
Ðû²¼Ê±¼ä:
2021-01-22
?
2021Äê1ÔÂ7ÈÕ £¬£¬£¬·Ñ³Ç¡£¡£¡£¡£¡£¡£¡£×¨×¢ÓÚ·¢Ã÷ºÍ¿ª·¢Á¢ÒìµÄÃâÒßÁÆ·¨µÄCARISMA Therapeutics Inc.Ðû²¼Íê³É4700ÍòÃÀÔªBÂÖÈÚ×Ê £¬£¬£¬Ê¹µÃ¹«Ë¾ÀÛ¼ÆÈÚ×ʽü1.09ÒÚÃÀÔª¡£¡£¡£¡£¡£¡£¡£
BÂÖͶ×ÊÓÉSymbiosis II £¬£¬£¬LLCǣͷ £¬£¬£¬ÐÂͶ×ÊÕßSolasta VenturesºÍLivzon Pharmaceutical Group Inc.£¨ÑÇÖÞ±ØÓ®Ò½Ò©¼¯ÍÅ£©¾ÙÐÐÁËͶ×Ê¡£¡£¡£¡£¡£¡£¡£±ðµÄ £¬£¬£¬¸ÃÂÖÈÚ×Ê»¹°üÀ¨AbbVie Ventures £¬£¬£¬HealthCap £¬£¬£¬Wellington Partners £¬£¬£¬IP Group £¬£¬£¬TPG Biotech £¬£¬£¬Agent CapitalºÍMRL Ventures Fund¡£¡£¡£¡£¡£¡£¡£
2018Äê6ÔÂ27ÈÕ £¬£¬£¬¸Ã¹«Ë¾Ðû²¼Íê³ÉÁË5300ÍòÃÀÔªAÂÖÈÚ×Ê¡£¡£¡£¡£¡£¡£¡£AÂÖÈÚ×ÊÓÉAbbVie VenturesºÍHealthCapǣͷ £¬£¬£¬ÆäÖаüÀ¨ÏÖÓеÄÖÖ×ÓͶ×ÊÕßIP Group £¬£¬£¬Penn MedicineºÍGrazia EquityÒ²¼ÓÈë £¬£¬£¬ÐµÄͶ×ÊÕßWellington Partners, TPG Biotech, MRL Ventures FundºÍAgent Capital¡£¡£¡£¡£¡£¡£¡£
Õâ±Ê×ʽð½«ÓÃÓÚÍƽøÄ¿½ñµÄÑз¢ºÍ·¢Ã÷ÏîÄ¿ £¬£¬£¬°üÀ¨CARISMAµÄÖ÷ÒªºòÑ¡Ò©ÎïCT-0508£¨¿¹È˱íƤÉú³¤Òò×ÓÊÜÌå2£¨HER2£©°ÐÏòǶºÏ¿¹ÔÊÜÌå¾ÞÊÉϸ°û£¨CAR-M£©£©µÄIÆÚÁÙ´²ÊÔÑé¡£¡£¡£¡£¡£¡£¡£¸Ã»ú¹¹×î½üÆô¶¯ÁËCAR-MµÄͬÀàÑо¿ £¬£¬£¬Ê×´ÎÈËÀàÑо¿µÄÊÔÑéÈë×éºÍ»¼Õßɸѡ¡£¡£¡£¡£¡£¡£¡£Õâ±Ê×ʽ𻹽«Ê¹CARISMAÄܹ»½øÒ»²½¿ª·¢ÆäרÓеŤ³Ì¾ÞÊÉϸ°ûƽ̨ £¬£¬£¬¼ÌÐøÀ©Õ¹°©Ö¢Ë³Ó¦Ö¢µÄ¹ÜÏß £¬£¬£¬²¢Ê¹¸Ãƽ̨Äܹ»Ó¦ÓÃÓÚ°©Ö¢ÒÔÍâµÄ¼²²¡ÁìÓò¡£¡£¡£¡£¡£¡£¡£
CARISMA Therapeutics×ܲüæÊ×ϯִÐйÙSteven KellyÌåÏÖ£º£º“ÎÒÃÇÕý´¦ÓÚÁìÏȵÄתÕ۵㠣¬£¬£¬ÑÇÖÞ±ØӮǣͷÏîÄ¿ÒÑÕýʽ½øÈëÆÀ¹ÀµÄÁÙ´²ÊÔÑé½×¶Î¡£¡£¡£¡£¡£¡£¡£Õâ±ÊÌØÁíÍâ×ʽð½«Ê¹ÎÒÃÇÄܹ»½øÒ»²½ÍƽøÆÀ¹À¹¤³Ì¾ÞÊÉϸ°ûDZÁ¦µÄʹÃü¡£¡£¡£¡£¡£¡£¡£” “ÎÒÃÇлл°üÀ¨SymBiosis II £¬£¬£¬LLCÔÚÄÚµÄеĺÍÏÖÓеÄͶ×ÊÕßµÄÖ§³Ö £¬£¬£¬SymBiosis II £¬£¬£¬LLCÔÚרעÓÚÖ×ÁöѧºÍÉúÎïÖÎÁƹ«Ë¾µÄͶ×Ê·½ÃæÓµÓÐÓÅÒìµÄÍù¼¨¡£¡£¡£¡£¡£¡£¡£”
CARISMAµÄ·¢Ã÷ºÍ¿ª·¢ÊÂÇ鼯ÖÐÔÚ±öϦ·¨ÄáÑÇ´óѧ¿ª·¢µÄרÓÐCAR-Mƽ̨ÉÏ £¬£¬£¬¸Ãƽּ̨ÔÚ½â¾öÆäËûϸ°ûÁÆ·¨ÔÚÖÎÁÆʵÌåÁöʱÓöµ½µÄÌôÕ½ £¬£¬£¬ÀýÈçÖ×Áö²¿Î»µÄµÝËÍÊÜÏÞ £¬£¬£¬ÃâÒßÒÖÖÆÐÔÖ×Áö΢ÇéÐκÍÖ×ÁöÏà¹Ø¿¹ÔµÄÒìÖʱí´ï¡£¡£¡£¡£¡£¡£¡£CARISMAµÄÁÙ´²Ç°·¢Ã÷ÔÚ¡¶ÓÃÓÚ°©Ö¢ÃâÒßÁÆ·¨µÄÈËÀàǶºÏ¿¹ÔÊÜÌå¾ÞÊÉϸ°û¡·ÖиÅÊö £¬£¬£¬²¢½ÒÏþÔÚ¡¶×ÔÈ»ÉúÎïÊÖÒÕ¡·£¨2020Äê3Ô£©ÉÏ £¬£¬£¬Åú×¢CAR-MÁÆ·¨¿ÉÄܾßÓÐսʤÕâЩÌôÕ½µÄDZÁ¦¡£¡£¡£¡£¡£¡£¡£
CARISMAµÄÄ¿µÄÊdzÉΪµÚÒ»¼ÒΪÍíÆÚʵÌåÁö»¼Õß¿ª·¢»ùÓÚCAR-MµÄÁÆ·¨µÄ¹«Ë¾ £¬£¬£¬²¢ÕýÔÚÃÀ¹úµÄÁ½¸öÑо¿ÖÐÐÄ£º£º±öϦ·¨ÄáÑÇ´óѧºÍ±±¿¨ÂÞÀ´ÄÉ´óѧÆô¶¯CT-0508£¨Õë¶ÔHER2µÄCAR-M£©µÄIÆÚÁÙ´²ÊÔÑé¡£¡£¡£¡£¡£¡£¡£CARISMAÔÚÁÙ´²Ç°²âÊÔÖжÔCT-0508µÄÑо¿ÒѾÏÔʾ³öÆäCAR-Mƽ̨µÄDZÁ¦ÒÔ¼°ÔÚ¶à¸öÖÎÁÆÁìÓò£¨°üÀ¨HER2¹ý±í´ïµÄʵÌåÁö£©µÄDZÔÚÊÊÓÃÐÔ £¬£¬£¬ÕâÒ»ÆðÔ´µÄÁÙ´²Ñо¿½«¶Ô´Ë¾ÙÐÐ̽ÌÖ¡£¡£¡£¡£¡£¡£¡£
“ÎÒÃǺÜÐË·Ü¿´µ½¶àÄêÀ´¶ÔCAR-Mƽ̨DZÁ¦µÄÑо¿×îÖÕÔÚÕâÏîÈËÀàÊ×´ÎÁÙ´²ÊÔÑéÖеִïÁË¸ß·å £¬£¬£¬” Michael Klichinsky, PharmD, PhD, CAR-MÊÖÒÕÅäºÏ·¢Ã÷ÈË, CARISMA Therapeutics¿ÆѧÁªºÏÊ×´´È˼淢Ã÷¸±×ܲᣡ£¡£¡£¡£¡£¡£“Õ⽫Êǹ¤³Ì¾ÞÊÉϸ°ûÊ×´ÎÓÃÓÚÁÙ´²ÊÔÑé £¬£¬£¬ÎÒÃÇÆÚ´ý½øÒ»²½ÆÀ¹ÀÆä¶Ô»¼ÕßµÄDZÔÚÓ°Ïì¡£¡£¡£¡£¡£¡£¡£”
¹ØÓÚCARISMA Therapeutics Inc.
CARISMA Therapeutics Inc.ÊÇÒ»¼ÒÉúÎïÖÆÒ©¹«Ë¾ £¬£¬£¬ÖÂÁ¦ÓÚ¿ª·¢Õë¶Ô¹¤³Ì¾ÞÊÉϸ°ûµÄ²î±ð»¯×¨ÓÐϸ°ûÖÎÁÆƽ̨ £¬£¬£¬ÕâЩϸ°ûÔÚÏÈÌìºÍ˳ӦÐÔÃâÒßÓ¦´ðÖоùÆð×ÅÖÁ¹ØÖ÷ÒªµÄ×÷Óᣡ£¡£¡£¡£¡£¡£¸Ãƽ̨Óë±öϦ·¨ÄáÑÇ´óѧÏàÖú¿ª·¢µÄµÚÒ»¸öÓ¦ÓÃÏîÄ¿ÊÇÓÃÓÚÖÎÁÆʵÌåÁöµÄ×ÔÌåǶºÏ¿¹ÔÊÜÌ壨CAR£©¾ÞÊÉϸ°û¡£¡£¡£¡£¡£¡£¡£CARISMA Therapeutics×ܲ¿Î»ÓÚ±öϦ·¨ÄáÑÇÖݷѳǡ£¡£¡£¡£¡£¡£¡£
±öϦ·¨ÄáÑÇ´óѧÅåÀ׶ûÂüҽѧԺºÍ°¬²¼ÀÄ·É°©Ö¢ÖÐÐĵÄѪҺÖ×ÁöѧÖúÀí½ÌÊÚSaar Gill²©Ê¿ºÍ±öϦ·¨ÄáÑÇ´óѧ¶¼ÊÇCARISMAµÄÅäºÏÊ×´´ÈË £¬£¬£¬²¢³ÖÓиù«Ë¾µÄ¹ÉȨ¡£¡£¡£¡£¡£¡£¡£CARISMAÒÑ´Ó±öϦ·¨ÄáÑÇ´óѧ»ñµÃPennÓµÓеÄijЩ֪ʶ²úȨÔÊÐí £¬£¬£¬PerelmanҽѧԺµÄGill²©Ê¿ÊµÑéÊÒ»ñµÃÁ˸ù«Ë¾µÄÔÞÖúÑо¿×ʽ𡣡£¡£¡£¡£¡£¡£PennºÍGill²©Ê¿Î´À´Ò²¿ÉÄÜÓÐȨ´ÓCARISMAÔÊÐíºÍÑ¡ÔñµÄÊÖÒÕÖлñµÃÌØÁíÍâ¾¼ÃÀûÒæ¡£¡£¡£¡£¡£¡£¡£